Jacobs Levy Equity Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Sell |
|
|||||
|
2025
Q1 | $8.98M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.37M | Sell |
|
|||||
|
2023
Q4 | $31.7M | Sell |
|
|||||
|
2023
Q3 | $37.5M | Buy |
|
|||||
|
2023
Q2 | $34.3M | Buy |
|
|||||
|
2023
Q1 | $25M | Buy |
|
|||||
|
2022
Q4 | $216K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $2.2M | Sell |
|
|||||
|
2022
Q1 | $71.7M | Sell |
|
|||||
|
2021
Q4 | $61.7M | Buy |
|
|||||
|
2021
Q3 | $6.56M | Sell |
|
|||||
|
2021
Q2 | $29.3M | Sell |
|
|||||
|
2021
Q1 | $76.4M | Buy |
|
|||||
|
2020
Q4 | $226K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $640K | Buy |
|
|||||
|
2020
Q1 | $397K | Sell |
|
|||||
|
2019
Q4 | $10.4M | Sell |
|
|||||
|
2019
Q3 | $63.9M | Buy |
|
|||||
|
2019
Q2 | $52.6M | Sell |
|
|||||
|
2019
Q1 | $65.9M | Buy |
|
|||||
|
2018
Q4 | $67.2M | Buy |
|
|||||
|
2018
Q3 | $53.3M | Buy |
|
|||||
|
2018
Q2 | $41.3M | Buy |
|
|||||
|
2018
Q1 | $39.6M | Buy |
|
|||||
|
2017
Q4 | $36.1M | Buy |
|
|||||
|
2017
Q3 | $1.19M | Buy |
|
|||||
|
2017
Q2 | $1.01M | Buy |
|
|||||
|
2017
Q1 | $745K | Sell |
|
|||||
|
2016
Q4 | $27.7M | Sell |
|
|||||
|
2016
Q3 | $49.4M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $35.4M | Sell |
|
|||||
|
2015
Q3 | $47.7M | Buy |
|
|||||
|
2015
Q2 | $44.5M | Buy |
|
|||||
|
2015
Q1 | $271K | Sell |
|
|||||
|
2014
Q4 | $28.3M | Sell |
|
|||||
|
2014
Q3 | $58.1M | Buy |
|
|||||
|
2014
Q2 | $52.2M | Buy |
|
|||||
|
2014
Q1 | $35.5M | Buy |
|